tirzepatide pancreatitis incidence PDF] Acute Caused by Tirzepatide—Friend or Foe in Diabetic

operate in a unique niche within the market for weight loss drugs

For patients primarily using tirzepatide for type 2 diabetes management, other drug classes such as SGLT2 inhibitors or DPP-4 inhibitors may be appropriate alternatives in line with NICE guidance (NG28), though they lack the same degree of weight loss benefit

doi: 10.1016/j.celrep.2015.04.037 23 MavalliMDDiGirolamoDJFanYRiddleRCCampbellKSVan GroenTet al

First, verify that adequate time has elapsed for the medication to exert its full effects

Cardiovascular, mortality, and kidney outcomeswith GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomized trials